Dare Bioscience (DARE) Non-Current Assets (2013 - 2026)
Dare Bioscience's Non-Current Assets came in at $5.68 million for Q2 2026, down 10.9% from $6.38 million a year earlier.
Powered by 
Analysis
Dare Bioscience (DARE) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Dare Bioscience's Non-Current Assets was $5.41 million, up 48.1% from FY2024.
- Non-Current Assets carries a five-year compound annual growth rate of 57.0% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $3.65 million in FY2024 (-2.3%), $3.74 million in FY2023 (+374.7%), $787,630 in FY2022 (+54.1%) and $511,161 in FY2021 (-9.8%).
- The five-year range for quarterly Non-Current Assets is $511,161 (Q4 2021) to $6.8 million (Q1 2025).
- Year-over-year, Non-Current Assets increased in five of the last seven quarters, with growth averaging 56.0%.
- The fastest year-over-year change in Non-Current Assets over five years came in Q4 2023 (growth of 374.7%), and the weakest in Q1 2023 (a decline of 37.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Dare Bioscience | 10.13 Mn | -55.33 Mn | -132,343.00 | 5.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.68 Mn |
| Dec 31, 2025 | 5.41 Mn |
| Sep 30, 2025 | 5.74 Mn |
| Jun 30, 2025 | 6.38 Mn |
| Mar 31, 2025 | 6.80 Mn |
| Dec 31, 2024 | 3.65 Mn |
| Sep 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 2.78 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 3.74 Mn |
| Sep 30, 2023 | 2.62 Mn |
| Jun 30, 2023 | 966,665.00 |
| Mar 31, 2023 | 854,727.00 |
| Dec 31, 2022 | 787,630.00 |
| Sep 30, 2022 | 809,347.00 |
| Jun 30, 2022 | 1.28 Mn |
| Mar 31, 2022 | 1.37 Mn |
| Dec 31, 2021 | 511,161.00 |
| Sep 30, 2021 | 568,322.00 |
| Jun 30, 2021 | 763,190.00 |
API Access
Dare Bioscience Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=DARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "DARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=DARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();